To attempt to justify the expense of using propofol for day-surgery, we have compared propofol with methohexitone for induction of anaesthesia for elective minor gynaecological procedures. Seventy healthy patients were randomised to receive either induction agent and postoperatively they were compared for recovery times, side-effects and patient appraisal the following day. The results showed that propofol was superior to methohexitone for most parameters, with small but statistically significant differences in response time, ambulation time, vomiting and drowsiness during recovery. There were minor differences in patient appraisal the next day. However, it is doubtful whether the advantages of propofol are sufficiently substantial to justify the expense of its routine use in preference to methohexitone and its place is a matter for individual judgement.
Propofol is an intravenous anaesthetic agent which has recently become widely used for minor procedures and especially for day-surgery patients. It has been claimed that propofol offers rapid induction and clear-headed recovery with minimal nausea, vomiting or other side-effects.I-3 Propofol is also easy to use and has high patient acceptance. 4 However, it is a relatively expensive drug (over $10 per average anaesthetic dose).
Methohexitone has previously been a popular drug for induction and maintenance of anaesthesia in outpatients, because its use appears to be associated with a more rapid recovery than with other widely used intravenous anaesthetics such as thiopentone. However, methohexitone may be associated with excitatory side-effects during induction and excessive drowsiness has sometimes been noted during the early postoperative period. s It is a relatively inexpensive drug (less than $4 per average anaesthetic dose).
This study was designed to compare the postoperative side-effects, both immediate and delayed, of propofol and methohexitone used for induction of anaesthesia in patients having gynaecological day-surgery procedures. The hypothesis was that propofol was significantly better than methohexitone for this form of anaesthesia and that its relatively greater cost was thereby justified.
PATIENTS AND METHODS
Seventy healthy young women (ASA physical status I or 2) presenting for brief gynaecological procedures (less than 30 minutes duration) in daysurgery were entered into the study. There were no other criteria for entry, and the only criterion for exclusion was sensitivity to either induction agent. All patients gave written informed consent.
Apart from randomisation to receive either induction agent, all other aspects of the anaesthetic were unchanged from the Department's routine in such cases. Randomisation was based on whether the last digit of the patient's unit record number was odd or even. The actual agent given was thus known to the anaesthetist, but was unknown to the patient and to the recovery area nursing staff carrying out the evaluation.
Prior to surgery, a questionnaire was commenced with patient identification, preoperative assessment and details of prior anaesthetic experience. The patients were then anaesthetised with fentanyl 1.0 mcg/kg and either propofol 2.5 mg/kg or methohexitone 1.5 mg/kg via an antecubital vein, followed by N 2 0:0 2 3:1 and increments of the induction agent. Routine monitoring with ECG, non-invasive blood pressure measurement and pulse oximetry was performed, with these parameters being recorded at threeminute intervals. Formal data collection began after transfer to the recovery area. The following data were recorded: 1. The arrival time in the recovery area and the times to awaken, to respond to verbal command, to orientation, to ambulation and to discharge were tabulated. 2. Any side-effects, namely nausea, vomiting, anorexia, dizziness, drowsiness or headache, were noted. 3. Patients were given a questionnaire which was explained to them. They were requested to complete it the following day and return it by mail. This sought recollection of pain on injection and postoperative drowsiness, feeling unwell, headache, nausea, vomiting, time to eating, comparison with any previous anaesthetics and time to resumption of normal activities. 
RESULTS
Of the seventy patients, thirty-five received each induction agent. There were no statistically significant differences between the two groups with respect to age, weight, ASA status, smoking history, type and duration of surgery and return rate of questionnaire (Table 1) .
The recovery times are shown in Figure 1 . The times to respond to verbal command and to ambulation were significantly shorter after propofol than after methohexitone (P = 0.02 and P = 0.05, respectively). The times to awaken and to orientation were also shorter after propofol, but these differences were not statistically significant. The time to discharge was longer after propofol, but this difference was not statistically significant and may have been influenced more by social than by drug factors.
The side-effects noted during recovery are shown in Figure 2 . All side-effects were less frequent after propofol than after methohexitone, and the differences in vomiting and drowsiness were statistically significant (P = 0.04 and P = 0.01, respectively).
. Questionnaires were returned by 81 % of patIents overall, and the results are shown in Figure 3 . Drowsiness, feeling unwell, headache, nausea and vomiting, but not pain on injection, were less after propofol than after methohexitone, but ~ll .these differences were small and not statlstlcally significant. The time to eating was also less after propofol than after methohexitone [1.3 (1.6) hr v 3.2 (6.1) hr, respectively, mean (SO), P = NS].
Thirty per cent of patients had resumed normal activities on the day of operation, but about 45% did not do so until the following day and the remaining 25% not until some days later. Patients resumed normal activities sooner after methohexitone than after propofol ( there was a wide individual variation and this difference was not statistically significant.
When compared with a previous anaesthetic (Figure 4 ), the present experience was regarded as better by 60% of patients (68% after propofol and SO% after methohexitone) and worse by 20% (the same numbers in each treatment group), differences that were not statistically significant.
DISCUSSION
Anaesthesia for day-surgery patients requires rapid recovery and minimal residual effects to enable early discharge of patients. No intravenous induction agent has received universal acceptance, but propofol has proved popular for this indication since its introduction. 6 . s The perceived benefits of rapid recovery, minimal side-effects and high patient acceptance resulted in such widespread use Methohexitone ., propofol §I. of propofol at our own hospital that the Department of Anaesthetics last year achieved the distinction of the highest consumption of propofol of any department in Australia. The present trial was thus designed to determine whether the real benefits of propofol warranted this expense. The observations made fall into three groups. In all groups, most differences were in favour of propofol. First, there were statistically significant differences in ambulation time and drowsiness, Second, there were suggestive differences in responsiveness, nausea and vomiting. Third, there were some minor differences in return to normality as reported the next day. The operation performed may of course have contributed to a lack of wellbeing in some patients, but it was interesting to note that 2S% had delayed recovery, and further investigation of this group may be worthwhile. It was also of interest that by the time the patients had reached home, the frequency of headache had doubled (from 20% to 40%) in the methohexitone group and trebled (from just over 10% to over 30%) in the propofol group. This difference in frequency of headache before and after returning home was statistically significant in both groups,
Overall, this study probably does not support the routine use of propofol in preference to methohexitone on the basis of the observed clinical benefits during recovery, as these were quantitatively small even if some were statistically significant. If the perceived differences reported on later patient appraisal remained consistent, we would need to study 800 patients to have a 7S% chance of showing a statistically significant benefit (P < O.OS) of propofol over methohexitone for these parameters (except for resumption of normal activities, which was sooner after methohexitone than after propofol). Even then, the magnitude of the differences would probably not be such as to offer clinically significant benefit. Other previously observed advantages of propofol, including ease of use, surgical 'quiet' and patients' understanding of discussions before and after anaesthesia, were not examined in this study. A larger study including surgeons' opinions and psychological testing of patients might demonstrate such differences. However, on the basis of our present observations, propofol does not offer convincing costeffectiveness compared with methohexitone for day-surgery .
